tmc-310911 tmc-310911 tmc-310911 (also known as asc-09) is an antiviral drug which was originally researched as a treatment for hiv/aids. it is a protease inhibitor related to darunavir. while tmc-310911 was not ultimately developed as a medication for the treatment of aids, research has continued into potential applications in the treatment of other viral diseases, and in march 2020 it was entered into clinical trials for the treatment of covid-19. tmc-310911legal statuslegal status us: investigational drug identifiers iupac name furan-4-yl] n--1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate cas number1000287-05-7pubchem cid53361968drugbankdb15623chemspider34554561unii0151w500hpchemical and physical dataformulac38h53n5o7s2molar mass755.99 g·mol−13d model (jsmol)interactive image smiles cc(c)cn(c((cc1=cc=cc=c1)nc(=o)o2co32cco3)o)s(=o)(=o)c4=cc5=c(c=c4)n=c(s5)nc6ccn(cc6)c7cccc7 inchi inchi=1s/c38h53n5o7s2/c1-25(2)22-43(23-33(44)32(20-26-8-4-3-5-9-26)41-38(45)50-34-24-49-36-30(34)16-19-48-36)52(46,47)29-12-13-31-35(21-29)51-37(40-31)39-27-14-17-42(18-15-27)28-10-6-7-11-28/h3-5,8-9,12-13,21,25,27-28,30,32-34,36,44h,6-7,10-11,14-20,22-24h2,1-2h3,(h,39,40)(h,41,45)/t30-,32-,33+,34-,36+/m0/s1key:jqunfhfwxcxprk-ammmhqjvsa-n